Arcutis Biotherapeutics, Inc.

WESTLAKE VILLAGE, CA · Founded 2016 · CIK 0001787306 · Biotech · Public

Topical biologic therapies for immune-mediated skin diseases

arcutis.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$94M
1 Form D · Oct 2019
84 months since last filing
Contracts
—
No federal contracts on record
Patents
40
20 granted · 20 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$94,499,967
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2833Prelude Therapeutics—$97M
2834Coriell Life Sciences, Inc.—$10M
2835Tango Therapeutics—$95M
2836Arcutis Biotherapeutics, Inc.—$94M
2837OMNI BIO PHARMACEUTICAL, INC.—$28M
2838ReAlta Life Sciences, Inc.—$94M
2839Verve Therapeutics—$94M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 7 related persons
  • Alexander AsamDirector
  • Bhaskar ChaudhuriDirector
  • Daniel EstesDirector
  • Patrick HeronDirector
  • Jonathan SilversteinDirector
  • Ricky SunDirector
  • Todd WatanabeDirector · Executive Officer

Patents

USPTO · 20 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.